150 related articles for article (PubMed ID: 23769341)
41. Oscillatory Control of Notch Signaling in Development.
Kageyama R; Shimojo H; Isomura A
Adv Exp Med Biol; 2018; 1066():265-277. PubMed ID: 30030831
[TBL] [Abstract][Full Text] [Related]
42. XIAP associated factor 1 (XAF1) represses expression of X-linked inhibitor of apoptosis protein (XIAP) and regulates invasion, cell cycle, apoptosis, and cisplatin sensitivity of ovarian carcinoma cells.
Zhao WJ; Deng BY; Wang XM; Miao Y; Wang JN
Asian Pac J Cancer Prev; 2015; 16(6):2453-8. PubMed ID: 25824780
[TBL] [Abstract][Full Text] [Related]
43. Significance of achaete-scute complex homologue 1 (ASCL1) in pulmonary neuroendocrine carcinomas; RNA sequence analyses using small cell lung cancer cells and Ascl1-induced pulmonary neuroendocrine carcinoma cells.
Kudoh S; Tenjin Y; Kameyama H; Ichimura T; Yamada T; Matsuo A; Kudo N; Sato Y; Ito T
Histochem Cell Biol; 2020 Jun; 153(6):443-456. PubMed ID: 32170367
[TBL] [Abstract][Full Text] [Related]
44. Ptf1a-mediated control of Dll1 reveals an alternative to the lateral inhibition mechanism.
Ahnfelt-Rønne J; Jørgensen MC; Klinck R; Jensen JN; Füchtbauer EM; Deering T; MacDonald RJ; Wright CV; Madsen OD; Serup P
Development; 2012 Jan; 139(1):33-45. PubMed ID: 22096075
[TBL] [Abstract][Full Text] [Related]
45. Identification of DJ-1 as a contributor to multidrug resistance in human small-cell lung cancer using proteomic analysis.
Gao H; Niu Y; Li M; Fang S; Guo L
Int J Exp Pathol; 2017 Apr; 98(2):67-74. PubMed ID: 28580701
[TBL] [Abstract][Full Text] [Related]
46. Prognostic significance of Hes-1, a downstream target of notch signaling in hepatocellular carcinoma.
Zou JH; Xue TC; Sun C; Li Y; Liu BB; Sun RX; Chen J; Ren ZG; Ye SL
Asian Pac J Cancer Prev; 2015; 16(9):3811-6. PubMed ID: 25987042
[TBL] [Abstract][Full Text] [Related]
47. [Inhibitory effect and mechanism of (-)-epigallocatechin-3-gallate on HT29 and HCT-8 colorectal cancer cell lines and expression of HES1 and JAG1].
Zhang CX; Wang SM; Jin HY
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):636-9. PubMed ID: 21866461
[TBL] [Abstract][Full Text] [Related]
48. The COX-2 selective inhibitor-independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway.
Zhang H; Ye Y; Bai Z; Wang S
Dig Dis Sci; 2008 Aug; 53(8):2195-203. PubMed ID: 18320325
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
[TBL] [Abstract][Full Text] [Related]
50. The balance between the expressions of hASH1 and HES1 differs between large cell neuroendocrine carcinoma and small cell carcinoma of the lung.
Nasgashio R; Sato Y; Matsumoto T; Kageyama T; Hattori M; Iyoda A; Satoh Y; Ryuge S; Masuda N; Jiang SX; Saegusa M
Lung Cancer; 2011 Dec; 74(3):405-10. PubMed ID: 21601304
[TBL] [Abstract][Full Text] [Related]
51. Dynamic Ligand Discrimination in the Notch Signaling Pathway.
Nandagopal N; Santat LA; LeBon L; Sprinzak D; Bronner ME; Elowitz MB
Cell; 2018 Feb; 172(4):869-880.e19. PubMed ID: 29398116
[TBL] [Abstract][Full Text] [Related]
52. siRNA silencing EZH2 reverses cisplatin-resistance of human non-small cell lung and gastric cancer cells.
Zhou W; Wang J; Man WY; Zhang QW; Xu WG
Asian Pac J Cancer Prev; 2015; 16(6):2425-30. PubMed ID: 25824776
[TBL] [Abstract][Full Text] [Related]
53. Notch ligand Delta-like 1 promotes the metastasis of melanoma by enhancing tumor adhesion.
Zhang JP; Li N; Bai WZ; Qiu XC; Ma BA; Zhou Y; Fan QY; Shan LQ
Braz J Med Biol Res; 2014 Apr; 47(4):299-306. PubMed ID: 24714813
[TBL] [Abstract][Full Text] [Related]
54. Effects of p73 gene overexpression on apoptosis and chemosensitivity of human lung adenocarcinoma cell line A549.
He Y; Fan SZ; Jiang YG
Ai Zheng; 2006 Aug; 25(8):925-32. PubMed ID: 16965670
[TBL] [Abstract][Full Text] [Related]
55. An exquisite cross-control mechanism among endothelial cell fate regulators directs the plasticity and heterogeneity of lymphatic endothelial cells.
Kang J; Yoo J; Lee S; Tang W; Aguilar B; Ramu S; Choi I; Otu HH; Shin JW; Dotto GP; Koh CJ; Detmar M; Hong YK
Blood; 2010 Jul; 116(1):140-50. PubMed ID: 20351309
[TBL] [Abstract][Full Text] [Related]
56. ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.
Zheng M; Niu Y; Bu J; Liang S; Zhang Z; Liu J; Guo L; Zhang Z; Wang Q
Aging (Albany NY); 2021 Jan; 13(3):3554-3572. PubMed ID: 33495408
[TBL] [Abstract][Full Text] [Related]
57. The human lung cancer drug resistance-related gene BC006151 regulates chemosensitivity in H446/CDDP cells.
Li S; Shi H; Ji F; Wang B; Feng Q; Feng X; Jia Z; Zhao Q; Qian G
Biol Pharm Bull; 2010; 33(8):1285-90. PubMed ID: 20686220
[TBL] [Abstract][Full Text] [Related]
58. [The effect and mechanism of microRNA-21 on cis-dichlorodiamineplatinum resistance in lung cancer cell strain].
Ren L; Huang C; Liu YH; Yu Y; Lin L; Wen LJ
Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1454-8. PubMed ID: 27266356
[TBL] [Abstract][Full Text] [Related]
59. MiR-124 changes the sensitivity of lung cancer cells to cisplatin through targeting STAT3.
Qi MM; Ge F; Chen XJ; Tang C; Ma J
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5242-5250. PubMed ID: 31298375
[TBL] [Abstract][Full Text] [Related]
60. Hypoxia-inducible factor 1 promoter-induced JAB1 overexpression enhances chemotherapeutic sensitivity of lung cancer cell line A549 in an anoxic environment.
Hu MD; Xu JC; Fan Y; Xie QC; Li Q; Zhou CX; Mao M; Yang Y
Asian Pac J Cancer Prev; 2012; 13(5):2115-20. PubMed ID: 22901179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
